Neovasc Inc. Investments Change (Net)

Investments Change (Net) of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Investments Change (Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Investments Change (Net) for the quarter ending December 31, 2015 was $140 Thousand (a -97.68% decrease compared to previous quarter)
  • Year-over-year quarterly Investments Change (Net) decreased by -96.52%
  • Annual Investments Change (Net) for 2015 was $9.32 Million (a -185.52% decrease from previous year)
  • Annual Investments Change (Net) for 2014 was $-10.9 Million (a -Infinity% decrease from previous year)
  • Annual Investments Change (Net) for 2013 was $0 (a -100.0% decrease from previous year)
  • Twelve month Investments Change (Net) ending December 31, 2015 was $9.32 Million (a -0.21% decrease compared to previous quarter)
  • Twelve month trailing Investments Change (Net) increased by 318.22% year-over-year
Trailing Investments Change (Net) for the last four month:
31 Dec '15 30 Sep '15 30 Jun '15 31 Mar '15
$9.32 Million $9.34 Million $1.43 Million $2.23 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Investments Change (Net) of Neovasc Inc.

Most recent Investments Change (Net)of NVCN including historical data for past 10 years.

Interactive Chart of Investments Change (Net) of Neovasc Inc.

Neovasc Inc. Investments Change (Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2015 $0.14 $6.04 $-0.89 $4.03 $9.32
2014 $0.16 $-1.87 $-0.09 $-9.07 $-10.9
2013 $0.0 $0.0 $0.0 $0.0 $0.0
2012 $-0.01 $1.51 $1.0 $-1.0 $1.5
2011 $-1.5 $-1.5

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.